BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17658406)

  • 21. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric cell sorting combined with molecular chimerism analysis to detect minimal recurrent leukemia: good news and bad news.
    Lamb LS; Robbins NF; Abhyankar S; Joyce M; Stetler-Stevenson M; Henslee-Downey PJ; Gee AP
    Bone Marrow Transplant; 1997 Jun; 19(11):1157-61. PubMed ID: 9193762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute lymphoblastic leukemia.
    Melnick SJ
    Clin Lab Med; 1999 Mar; 19(1):169-86, vii. PubMed ID: 10403080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
    Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
    Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy: results from a single UK centre.
    Motwani J; Jesson J; Sturch E; Jones S; Eyre L; Short P; Davies P; Williams MD; Darbyshire PJ; Hill FG; Lawson S
    Br J Haematol; 2009 Jan; 144(1):133-5. PubMed ID: 19016737
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
    Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
    Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A; Gillis D; Hissaria P; Lewis I
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
    Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
    Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric immunophenotyping of cerebrospinal fluid specimens.
    Craig FE; Ohori NP; Gorrill TS; Swerdlow SH
    Am J Clin Pathol; 2011 Jan; 135(1):22-34. PubMed ID: 21173121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
    Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
    J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The changing scene of adult acute lymphoblastic leukemia.
    Vitale A; Guarini A; Chiaretti S; Foà R
    Curr Opin Oncol; 2006 Nov; 18(6):652-9. PubMed ID: 16988590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated detection of residual leukemic cells by consecutive immunolabeling for CD10 and fluorescence in situ hybridization for ETV6/RUNX1 rearrangement in childhood acute lymphoblastic leukemia.
    Alpár D; Kajtár B; Kneif M; Jáksó P; László R; Kereskai L; Pajor L
    Cancer Genet Cytogenet; 2007 Feb; 173(1):23-30. PubMed ID: 17284366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of flow cytometry to detect minimal residual disease in acute leukemia.
    Campana D; Coustan-Smith E
    Eur J Histochem; 1996; 40 Suppl 1():39-42. PubMed ID: 8839698
    [No Abstract]   [Full Text] [Related]  

  • 36. Precursor T-lymphoblastic lymphoma: Speedy diagnosis in FNA and effusion cytology by morphology, immunochemistry, and flow cytometry.
    Bhaker P; Das A; Rajwanshi A; Gautam U; Trehan A; Bansal D; Varma N; Srinivasan R
    Cancer Cytopathol; 2015 Sep; 123(9):557-65. PubMed ID: 26243719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of a chemiluminescent methodology for detection of minimal residual disease in childhood acute lymphoblastic leukemia.
    Lo Nigro L; Poli A; Mirabile E; Costantino F; Schilirò G
    Haematologica; 2001 Dec; 86(12):1314-6. PubMed ID: 11726326
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
    Schwarz AK; Stanulla M; Cario G; Flohr T; Sutton R; Möricke A; Anker P; Stroun M; Welte K; Bartram CR; Schrappe M; Schrauder A
    Ann Hematol; 2009 Sep; 88(9):897-905. PubMed ID: 19165483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry.
    Mejstríková E; Fronková E; Kalina T; Omelka M; Batinić D; Dubravcić K; Pospísilová K; Vásková M; Luria D; Cheng SH; Ng M; Leung Y; Kappelmayer J; Kiss F; Izraeli S; Stark B; Schrappe M; Trka J; Starý J; Hrusák O
    Pediatr Blood Cancer; 2010 Jan; 54(1):62-70. PubMed ID: 19760767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma.
    DiGiuseppe JA; Wood BL
    Cytometry B Clin Cytom; 2019 Jul; 96(4):256-265. PubMed ID: 31231940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.